Aims and scope

BMJ Simulation & Technology Enhanced Learning (BMJ STEL) provides a forum to share scholarly practices to advance the use of simulation and technology enhanced learning in the context of health and social care. This includes knowledge translation to improve clinical outcomes, health systems, patient experience and safety.

BMJ STEL seeks to contribute to research,innovation and knowledge translation drawing on diverse disciplines spanning science,technology, engineering and medicine, alongside the arts, humanities and social sciences.

BMJ STEL includes various article types on the use of simulation in education, training and professional development as well the increasingly diverse fields of innovative learning technologies:online and distance learning, MOOCs, Web 2.0 and Wikis, mobile learning technologies, serious gaming, podcasts, animation and other multimedia in both virtual and physical learning environments.

For information about the Editor-in-Chief and editorial team, please refer to the Editorial Board page.

Plan S compliance

BMJ Simulation & Technology Enhanced Learning is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and  Plan S compliance on our Author Hub.

Journal information

Ownership BMJ Simulation & Technology Enhanced Learning is owned by BMJ
Publication Model Subscription; with hybrid open access option
Frequency Quarterly issues
Launch Date 2014
Indexed by Web of Science Core Collection: Emerging Sources Citation Index; Scopus; Google Scholar; PubMed Central (BMJ Open Access Special Collection)
Digital Archives Portico, LOCKSS
Editorial Policies Policies on conflict of interest, human and animal rights and informed consent
Peer Review Model Single blind; the names of reviewers are hidden from the author. Peer review terms and conditions
Data Sharing BMJ STEL adheres to BMJ’s Tier 2 data sharing policy
Online ISSN 2056-6697

Journal Statistics (2020)

Acceptance rate: 40%

Time to first decision: 39 days (mean)
Time from acceptance to publication: 13 days (mean)

Scimago Journal rank (SJR): 0.22
Citescore: 1.4

2020 total content views: 44,100
2020 total Altmetric mentions: 1,790

The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.

How we get these metrics

To advertise

Rights and permissions


COPE logo

BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.


The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.